AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Two additional formulations of ensifentrine are currently in Phase 2 development for the treatment of COPD: dry powder inhaler ('DPI ... of global equities at prices individual investors can ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Approved yesterday by the FDA, Trelegy Ellipta is the first ever daily single-inhaler to combine a triple therapy for COPD, and could ... has driven down prices in the market, with pharma finding ...

As pharmaphorum's market access themed month commences, Dr Joanna Entwistle and Julia Glover explore market access barriers to nebulisers for asthma in the UK. &nbsp, Asthma is an inflammatory ...

We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at where Roivant Sciences Ltd.

Human Metapneumovirus or HMPV, is a respiratory illness. It has flu-like symptoms and appeared five years after the COVID-19 ...

Mosliciguat is an innovative inhaled medication designed for once-daily use and acts as a soluble guanylate cyclase (sGC) activator to treat pulmonary ... report about the cheapest AI stock.

Low-priced stocks under £20 present a unique opportunity for those seeking high returns with a modest investment. By carefully filtering, investors can pinpoint stocks with significant growth ...

A new year, new breakthroughs! Join us for our annual tradition of compiling and revealing the most interesting things ...

Legendary money managers are facing off in the Robin Hood Foundation's stock-picking contest. Here's who is winning and why.

Eden Research PLC - Oxfordshire, England-based developer of biopesticides for use in the global crop protection, animal health and consumer products industries - The firm expects to report revenue for ...